$0.01
(Market cap
$52 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
0.5
P/B Ratio
4.5
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$4 Mln
-
ROE
0.2 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
4.7
-
Debt to Equity
--
-
Book Value
$--
-
EPS
$--
-
Face value
--
-
Shares outstanding
107,821,231
Years Aggregate
CFO
$--
EBITDA
$--
Net Profit
$--
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Impact BioMedical, Inc (IBO)
| -- | -- | -- | -23.2 | -- | -55.3 | -- |
|
BSE Sensex*
| -9.0 | 0.3 | 1.6 | -4.6 | 5.9 | 6.5 | 10.7 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Impact BioMedical, Inc (IBO)
|
0.4 | 51.8 | 0.0 | 0.8 | -4,411.4 | 6.9 | 0.5 | 4.5 |
| 88.6 | 12,304.7 | 669.5 | -320.0 | -0.8 | -71.1 | -- | 26.4 | |
| 249.4 | 16,614.0 | 1,054.4 | 755.9 | 5.7 | -- | 19.4 | 10.1 | |
| 77.9 | 10,682.6 | 71.0 | -894.0 | -1,175.8 | -- | -- | 60.3 | |
| 55.3 | 13,400.0 | 2,435.9 | 860.6 | 31.0 | 43 | 17 | 7.3 | |
| 106.9 | 12,277.1 | 1,663.7 | 413.6 | 36.3 | 430 | 31.2 | 83.9 | |
| 543.7 | 11,938.8 | 1,283.9 | -325.1 | -19.0 | -57.7 | -- | 22.9 | |
| 611.6 | 17,326.2 | 2,782.3 | 491.5 | 21.1 | 110.1 | 36.5 | 39.4 | |
| 367.9 | 10,496.2 | 0.0 | -339.1 | -- | -30.6 | -- | 7.6 | |
| 149.5 | 9,985.8 | 282.0 | 82.9 | -28.6 | 11.4 | 147 | 11.6 |
Shareholding Pattern
View DetailsAbout Impact BioMedical, Inc (IBO)
Impact BioMedical Inc. discovers, develops, and commercializes products and technologies to address unmet needs in human healthcare and wellness for specialty biopharmaceuticals, antivirals, antimicrobials, consumer healthcare, and wellness products... in the United States. The company provides Linebacker, a platform of small molecule electrophilically enhanced polyphenol compounds with application in oncology, inflammatory disorders, and neurology; and Laetose technology that is derived from a unique combination of sugar and inositol, which can inhibit the inflammatory and metabolic response of sugar alone. It also develops functional fragrance formulation, a suite of functional fragrances containing specialized botanical ingredients with application as an antimicrobial, and as an additive in insect repellents, detergents, lotions, shampoo, fabrics, and other substances. In addition, the company develops Equivir/Equivir G technology, a novel blend of polyphenols, which have demonstrated antiviral effects for use as health supplements and medications. Further, it is developing 3F (functional fragrance formulation), a formulation of botanical ingredients. Impact BioMedical Inc. was incorporated in 2018 and is based in Houston, Texas. Impact BioMedical Inc. operates as a subsidiary of DSS BioHealth Security, Inc Read more
-
CFO. Secretary & Treasurer
Mr. Todd D. Macko
-
Chairman & CEO
Mr. Frank D. Heuszel Esq., J.D.
-
Headquarters
Houston, TX
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Impact BioMedical, Inc (IBO)
What is the current share price of Impact BioMedical, Inc (IBO) Today?
The share price of Impact BioMedical, Inc (IBO) is $0.44 (NYSE) as of 27-Aug-2026 16:00 EDT. Impact BioMedical, Inc (IBO) has given a return of -23.17% in the last 1 years.
What is the current PB & PE ratio of Impact BioMedical, Inc (IBO)?
The P/E ratio of Impact BioMedical, Inc (IBO) is 0.55 times as on 21-Aug-2026.
The P/B ratio of Impact BioMedical, Inc (IBO) is 4.50 times as on 21-Aug-2026, a 16 discount to its peers’ median range of 5.35 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
-- |
-- |
2024 |
-0.68 |
3.92 |
2023 |
-- |
-- |
2022 |
-- |
-- |
2021 |
-0.21 |
0.04 |
What is the 52 Week High and Low of Impact BioMedical, Inc (IBO)?
The 52-week high and low of Impact BioMedical, Inc (IBO) are Rs 0.73 and Rs 0.37 as of 28-Aug-2026.
What is the market cap of Impact BioMedical, Inc (IBO)?
Impact BioMedical, Inc (IBO) has a market capitalisation of $ 52 Mln as on 21-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Impact BioMedical, Inc (IBO)?
Before investing in Impact BioMedical, Inc (IBO), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.